Study the economic and social effects on the population with a view to future regulation. These are the objectives of experimental legalization in Switzerland, commissioned by the FOPH (Federal Office of Public Health), which is involving more and more cities.
In fact, the project already left in Basel, Zurich and Lausanne, and soon also in Bern, Lucerne, Biel and Geneva, it will also expand to the municipality of Allschwil in the canton of Basel-Landschaft, but with a big novelty.
In fact, if until now the controlled sale of cannabis, permitted only to a group of selected adults, has only been authorized in pharmacies, in the new project cannabis will be sold by a specific dispensary, similar to those in the USA.
Switzerland's first cannabis dispensary is on its way
Grashaus projects, this is the name of the new project recently approved by the Swiss Institute for Addiction and Health Research (ISGF) and Sanity Group, in which they will participate well 4 thousand adults.
Furthermore, after Allschwil, where the study is expected to start and last for 5 years at the end of 2023, a new cannabis shop is expected to open in Liestal. Here consumers will be able to purchase various products, such as: flowers, hashish, extracts, edibles and vaping liquids.
"Participants who are accepted into the study will be able to legally obtain cannabis using an participation card. And ongoing surveys of participants' consumption behavior and physical and mental health will take place every three to six months," he said Michael Schaub, the scientific director of the ISGF who will lead the initiative.
“The results of the study can contribute to an informed health policy debate regarding the responsible use of cannabis and serve as a basis for making decisions on long-term regulation”, concluded Shaub.
